Literature DB >> 19249912

Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.

J Krijt1, Y Fujikura, L Sefc, M Vokurka, T Hlobenová, E Necas.   

Abstract

Hepcidin is a key regulator of iron homeostasis, while hemojuvelin is an important component of the hepcidin regulation pathway. It has been recently proposed that soluble hemojuvelin, produced from hemojuvelin by the protease furin, decreases hepcidin expression. The aim of the presented study was to examine the downregulation of hepcidin by chronic bleeding in hemojuvelin-mutant mice. Male mice with targeted disruption of the hemojuvelin gene (Hjv-/- mice) and wild-type littermates were maintained on an iron-deficient diet and subjected to weekly phlebotomies for 7 weeks. Gene expression was examined by real-time PCR. In wild type mice, repeated bleeding decreased hepcidin mRNA by two orders of magnitude. In Hjv-/- mice, basal hepcidin expression was low; however, repeated bleeding also decreased hepcidin mRNA content by an order of magnitude. Phlebotomies reduced hepatic iron overload in Hjv-/- mice by 80 %. Liver and muscle furin mRNA content was not significantly changed. No effect on hepatic Tmprss6 mRNA content was observed. Results from the study indicate that soluble hemojuvelin is not the sole factor responsible for hepcidin downregulation. In addition, the presented data suggest that, under in vivo conditions, tissue hypoxia does not transcriptionally regulate the activity of furin or TMPRSS6 proteases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249912     DOI: 10.33549/physiolres.931706

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  7 in total

1.  Novel tools for the evaluation of iron metabolism.

Authors:  Léon Kautz; Elizabeta Nemeth
Journal:  Haematologica       Date:  2010-12       Impact factor: 9.941

2.  The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo.

Authors:  An-Sheng Zhang; Junwei Gao; Dwight D Koeberl; Caroline A Enns
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis.

Authors:  An-Sheng Zhang
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

4.  Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein.

Authors:  An-Sheng Zhang; Sheila A Anderson; Jiaohong Wang; Fan Yang; Kristina DeMaster; Riffat Ahmed; Christopher P Nizzi; Richard S Eisenstein; Hidekazu Tsukamoto; Caroline A Enns
Journal:  Blood       Date:  2010-11-29       Impact factor: 22.113

5.  Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.

Authors:  Maria Mastrogiannaki; Pavle Matak; Jacques R R Mathieu; Stéphanie Delga; Patrick Mayeux; Sophie Vaulont; Carole Peyssonnaux
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

6.  Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?

Authors:  J Malyszko; J S Malyszko; N Levin-Iaina; E Koc-Zorawska; P Kozminski; M Mysliwiec
Journal:  Int Urol Nephrol       Date:  2011-12-01       Impact factor: 2.370

7.  Liver and muscle hemojuvelin are differently glycosylated.

Authors:  Yuzo Fujikura; Jan Krijt; Emanuel Nečas
Journal:  BMC Biochem       Date:  2011-09-21       Impact factor: 4.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.